MC
IBB icon

Moors & Cabot’s iShares Biotechnology ETF IBB Stock Holding History

Moors & Cabot’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Hold
9,041
– – 0.07% 265
2025
Q4 		$1.53M Buy
9,041
+17
+0.2% +$2.76K 0.07% 265
2025
Q3 		$1.3M Sell
9,024
-19,124
-68% -$2.61M 0.06% 297
2025
Q2 		$3.56M Sell
28,148
-905
-3% -$111K 0.17% 122
2025
Q1 		$3.72M Buy
29,053
+558
+2% +$75.7K 0.19% 111
2024
Q4 		$3.77M Sell
28,495
-87
-0.3% -$12.2K 0.18% 112
2024
Q3 		$4.16M Sell
28,582
-459
-2% -$66.4K 0.21% 102
2024
Q2 		$3.99M Sell
29,041
-322
-1% -$43K 0.21% 96
2024
Q1 		$4.03M Buy
29,363
+850
+3% +$116K 0.22% 96
2023
Q4 		$3.87M Buy
28,513
+412
+1% +$50.3K 0.24% 93
2023
Q3 		$3.44M Sell
28,101
-606
-2% -$77.1K 0.23% 97
2023
Q2 		$3.64M Sell
28,707
-605
-2% -$78.6K 0.24% 96
2023
Q1 		$3.79M Buy
29,312
+174
+0.6% +$22.8K 0.26% 93
2022
Q4 		$3.83M Sell
29,138
-95
-0.3% -$12.3K 0.27% 89
2022
Q3 		$3.42M Sell
29,233
-484
-2% -$60.1K 0.26% 88
2022
Q2 		$3.5M Sell
29,717
-12
-0% -$1.42K 0.25% 92
2022
Q1 		$3.87M Buy
29,729
+726
+3% +$94.6K 0.24% 97
2021
Q4 		$4.43M Buy
29,003
+1,029
+4% +$159K 0.27% 85
2021
Q3 		$4.52M Buy
27,974
+24
+0.1% +$4.04K 0.28% 79
2021
Q2 		$4.57M Sell
27,950
-199
-0.7% -$30.7K 0.32% 71
2021
Q1 		$4.24M Buy
28,149
+2,507
+10% +$398K 0.32% 71
2020
Q4 		$3.88M Sell
25,642
-280
-1% -$40K 0.33% 72
2020
Q3 		$3.51M Buy
25,922
+8,649
+50% +$1.17M 0.33% 69
2020
Q2 		$2.36M Buy
17,273
+8,810
+104% +$1.12M 0.25% 91
2020
Q1 		$909K Sell
8,463
-125
-1% -$14.4K 0.13% 165
2019
Q4 		$1.03M Sell
8,588
-215
-2% -$24K 0.1% 203
2019
Q3 		$868K Buy
8,803
+214
+2% +$22.4K 0.1% 216
2019
Q2 		$937K Sell
8,589
-1,018
-11% -$108K 0.12% 186
2019
Q1 		$1.08M Sell
9,607
-87
-0.9% -$9.54K 0.15% 155
2018
Q4 		$937K Buy
9,694
+672
+7% +$71.3K 0.15% 158
2018
Q3 		$1.09M Buy
9,022
+1,512
+20% +$178K 0.13% 177
2018
Q2 		$823K Buy
7,510
+1,730
+30% +$185K 0.11% 206
2018
Q1 		$617K Buy
5,780
+2,198
+61% +$244K 0.08% 275
2017
Q4 		$382K Buy
3,582
+1,617
+82% +$173K 0.05% 370
2017
Q3 		$218K Buy
+1,965
New +$210K 0.03% 475
2016
Q1 		– Sell
-3,930
Closed -$445K – 542
2015
Q4 		$445K Sell
3,930
-168
-4% -$18.2K 0.08% 274
2015
Q3 		$413K Sell
4,098
-96
-2% -$11.5K 0.08% 290
2015
Q2 		$516K Buy
4,194
+126
+3% +$15.1K 0.08% 276
2015
Q1 		$466K Sell
4,068
-582
-13% -$64.2K 0.08% 281
2014
Q4 		$470K Sell
4,650
-450
-9% -$43.7K 0.08% 273
2014
Q3 		$466K Buy
5,100
+450
+10% +$39.5K 0.08% 269
2014
Q2 		$398K Buy
4,650
+75
+2% +$5.91K 0.07% 317
2014
Q1 		$361K Buy
+4,575
New +$381K 0.09% 240

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moors & Cabot's IBB Position: Q1 2026 in Review

Moors & Cabot held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 9,041 shares worth $1.53M. The position accounts for 0.07% of the portfolio, ranked #265.

Moors & Cabot first reported a position in IBB in Q1 2014 and has held it in 43 quarters since. The position peaked at $4.57M in Q2 2021. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Moors & Cabot held 9,041 shares of iShares Biotechnology ETF worth $1.53M as of Q1 2026.
  • Moors & Cabot left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.07% of Moors & Cabot's portfolio in Q1 2026, its #265 holding.
  • Moors & Cabot first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 43 quarters since.
  • Moors & Cabot's iShares Biotechnology ETF position peaked at $4.57M in Q2 2021.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.